NCT07548073

Brief Summary

Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline, including impairments in orientation, memory, and daily functioning. Orientation dysfunction, involving difficulties in recognizing time, place, and person, is a common and clinically significant feature in patients with mild to moderate AD. This study aims to evaluate the effectiveness of a scenario-based reenactment training program in improving cognitive function and orientation ability in patients with mild to moderate Alzheimer's disease. The intervention is based on patients' real-life experiences and uses personalized visual materials (e.g., photos and videos) to reconstruct familiar scenarios, thereby enhancing cognitive stimulation and environmental recognition. In this prospective controlled study, participants will be assigned to either a scenario-based training group or a usual care group. The intervention group will receive structured training sessions three times per week for 3 months, followed by a 6-month follow-up period. The control group will receive standard care without structured cognitive training. The primary outcome is global cognitive function assessed by the Montreal Cognitive Assessment (MoCA). Secondary outcomes include orientation function, depressive symptoms, anxiety levels, quality of life, and intervention feasibility. This study aims to provide evidence for a practical, non-pharmacological intervention to improve cognitive and functional outcomes in patients with Alzheimer's disease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
126

participants targeted

Target at P50-P75 for not_applicable alzheimer-disease

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2024

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2025

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

April 14, 2026

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 23, 2026

Completed
Last Updated

April 23, 2026

Status Verified

April 1, 2026

Enrollment Period

12 months

First QC Date

April 14, 2026

Last Update Submit

April 20, 2026

Conditions

Keywords

Alzheimer's diseaseorientation impairmentcognitive interventionscenario-based trainingreenactment therapynon-pharmacological interventionMoCAcognitive function

Outcome Measures

Primary Outcomes (1)

  • Global Cognitive Function Assessed by Montreal Cognitive Assessment (MoCA)

    Global cognitive function will be assessed using the Montreal Cognitive Assessment (MoCA), a validated 30-point scale ranging from 0 to 30, with higher scores indicating better cognitive performance. The MoCA evaluates multiple cognitive domains including attention, executive function, memory, language, visuospatial ability, and orientation.

    Baseline and 3 months after intervention

Secondary Outcomes (7)

  • Orientation Function Assessed by MoCA Orientation Subscore

    Baseline and 3 months after intervention

  • Depressive Symptoms Assessed by GDS-15

    Baseline and 3 months after intervention

  • Anxiety Levels Assessed by GAI-20

    Baseline and 3 months after intervention

  • Cognitive Outcome Transitions

    Baseline to 3 months

  • Intervention Adherence

    During the 3-month intervention period

  • +2 more secondary outcomes

Study Arms (2)

Scenario-Based Reenactment Training

EXPERIMENTAL

Participants receive structured scenario-based reenactment training in addition to usual care. The intervention is based on patients' real-life experiences and utilizes personalized visual materials such as photographs and videos to reconstruct familiar scenarios. Training is conducted three times per week for 3 months, with each session lasting approximately 30-45 minutes. The program targets temporal, spatial, and person orientation to improve cognitive function.

Behavioral: Scenario-Based Reenactment Training

Usual Care

ACTIVE COMPARATOR

Participants receive standard medical and nursing care without structured cognitive intervention. Routine care includes pharmacological treatment, basic nursing support, and general health education.

Other: Usual Care

Interventions

Scenario-based reenactment training is a structured, personalized cognitive intervention designed to improve orientation and cognitive function in patients with Alzheimer's disease. The intervention is based on patients' real-life experiences and utilizes individualized visual materials, such as photographs and videos, to reconstruct familiar temporal, spatial, and interpersonal scenarios. Participants engage in guided recognition, recall, and contextual judgment tasks targeting orientation domains (time, place, and person). The intervention is delivered three times per week for 3 months, with each session lasting approximately 30-45 minutes. Training is conducted by trained healthcare providers or caregivers, both in hospital and home settings, with ongoing supervision to ensure consistency and adherence.

Scenario-Based Reenactment Training

Participants receive standard medical and nursing care without structured cognitive intervention. Routine care includes pharmacological treatment, basic nursing support, and general health education.

Usual Care

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 60 years
  • Diagnosis of mild to moderate Alzheimer's disease according to DSM-5 criteria
  • Ability to communicate and complete cognitive assessments
  • Stable caregiver available to assist with intervention and follow-up
  • Visual and auditory function adequate to participate in assessments (with or without correction)
  • Willingness to participate and provide informed consent (by patient or legal guardian)

You may not qualify if:

  • Severe psychiatric disorders (e.g., severe depression, schizophrenia)
  • Severe cardiovascular, cerebrovascular, or other systemic diseases affecting participation
  • History of neurological disorders other than Alzheimer's disease (e.g., Parkinson's disease, stroke with major deficits)
  • Severe sensory impairment (vision or hearing) that interferes with intervention or assessment
  • Inability to complete study procedures or comply with follow-up
  • Participation in other interventional clinical trials within the past 3 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tongde Hospital of Zhejiang Province

Hangzhou, Zhejiang, 310012, China

Location

MeSH Terms

Conditions

Alzheimer DiseaseCognitive Dysfunction

Condition Hierarchy (Ancestors)

DementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental DisordersCognition Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcome assessors were blinded to group allocation to minimize assessment bias. Participants and care providers were not blinded due to the nature of the intervention.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants are assigned to either a scenario-based reenactment training group or a usual care group in parallel. The intervention group receives structured cognitive training, while the control group receives standard care without structured intervention.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Department of Neurology

Study Record Dates

First Submitted

April 14, 2026

First Posted

April 23, 2026

Study Start

January 1, 2024

Primary Completion

December 30, 2024

Study Completion

June 30, 2025

Last Updated

April 23, 2026

Record last verified: 2026-04

Locations